drugset / Trial / NCT01206595
Safety, Efficacy, and Pharmacokinetics of SKY0402 Administered as a Nerve Block in Subjects Undergoing Bunionectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study was to determine the appropriate dose of SKY0402 administered as a nerve block for the management of postoperative pain following bunionectomy.
Timeline
- Start
- 2005-03
- Primary completion
- 2006-03
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 125 mg | Other |
| Comparator | SKY0402 | Unknown | 175 mg | Other |
| Comparator | SKY0402 | Unknown | 225 mg | Other |
| Comparator | SKY0402 | Unknown | 350 mg | Other |
Indications
No indication recorded.